High energy resolution fast XPS combined with TPD experiments were used to study the effect of chemisorbed oxygen on the adsorption and dissociation of NH(3) on Ir(110). Below 250 K the presence of O(ad) does not influence NH(3) decomposition. Above 250 K O(ad) enhances NH(3) dissociation, which results in three times as much N(2) formation and less molecular NH(3) desorption compared to the experiments without O(ad). The effect of O(ad) can be attributed to destabilization of NH(ad) on the surface, resulting in a further dehydrogenation towards N(ad). The presence of O(ad) on the surface lowers the temperature at which the N(ad) combination reaction takes place by as much as 200 K, due to repulsive interaction between N(ad) and O(ad). NO is formed above 450 K if both N(ad) and O(ad) are present on the surface.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/b502350e | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Room-Temperature Selective Detection of H by Pd Nanoparticle-Decorated SnO@WO Core-Shell Hollow Structures.
Anal Chem
January 2025
School of Metallurgy, Northeastern University, Shenyang 110819, China.
Sensitive H sensors play key roles in the large-scale and safe applications of H. In this study, we developed novel ternary Pd-loaded SnO@WO core-shell structures by hydrothermal and reduction methods. The compositions of the optimized ternary core-shell structures (Pd-SW-2) are prepared on the basis of the optimal binary core-shell structures (SW-X) according to the sensing performances to H.
View Article and Find Full Text PDFImplications of frequent hitter E3 ligases in targeted protein degradation screens.
Nat Chem Biol
January 2025
Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
Targeted protein degradation (TPD) offers a promising approach for chemical probe and drug discovery that uses small molecules or biologics to direct proteins to the cellular machinery for destruction. Among the >600 human E3 ligases, CRBN and VHL have served as workhorses for ubiquitin-proteasome system-dependent TPD. Identification of additional E3 ligases capable of supporting TPD would unlock the full potential of this mechanism for both research and pharmaceutical applications.
View Article and Find Full Text PDFLaboratory Studies of the Clathrate Hydrate Formation in the Carbon Dioxide-Water Mixtures at Interstellar Conditions.
ACS Omega
January 2025
Faculty of Physics and Technology, Al-Farabi Kazakh National University, Al-Farabi ave. 71/23, 050040 Almaty, Kazakhstan.
This study investigates the formation of carbon dioxide clathrate hydrates under conditions simulating interstellar environments, a process of significant astrophysical and industrial relevance. Clathrate hydrates, where gas molecules are trapped within water ice cages, play an essential role in both carbon sequestration strategies and understanding of the behavior of ices in space. We employed a combination of Fourier Transform Infrared (FTIR) spectroscopy, mass spectrometry, temperature-programmed desorption (TPD), and Density Functional Theory (DFT) calculations to explore thin films of HO:CO ice mixtures with varying CO concentrations (5-75%) prepared by vapor deposition at temperatures ranging between 11 and 180 K.
View Article and Find Full Text PDFA novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatment.
Theranostics
January 2025
Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Proteolysis Targeting Chimeras (PROTACs) are bifunctional compounds that have been extensively studied for their role in targeted protein degradation (TPD). The capacity to degrade validated or undruggable targets provides PROTACs with significant potency in cancer therapy. However, the clinical application of PROTACs is limited by their poor potency and unfavorable pharmacokinetic properties.
View Article and Find Full Text PDFDrug Discovery Approaches to Target E3 Ligases.
Chembiochem
January 2025
Department de Farmacia I Tecnología Farmacèutica, I Fisicoquímica, Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain.
Targeting E3 ligases is a challenging area in drug discovery. Despite the human genome encoding for more than 600 E3 ubiquitin ligases, only a handful of E3 ligases have been pharmacologically modulated or exploited for targeted protein degradation (TPD) strategies. The main obstacle for hijacking these E3 ligases is the lack of small-molecule ligands.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!